- Home
- JWN vs KYMR Comparison
JWN vs KYMR Comparison
Compare JWN & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JWN
- KYMR
- Stock Information
- Founded
- JWN 1901
- KYMR 2015
- Country
- JWN United States
- KYMR United States
- Employees
- JWN N/A
- KYMR N/A
- Industry
- JWN Clothing/Shoe/Accessory Stores
- KYMR Medicinal Chemicals and Botanical Products
- Sector
- JWN Consumer Discretionary
- KYMR Health Care
- Exchange
- JWN Nasdaq
- KYMR Nasdaq
- Market Cap
- JWN 3.7B
- KYMR 3.0B
- IPO Year
- JWN N/A
- KYMR 2020
- Fundamental
- Price
- JWN $22.86
- KYMR $41.96
- Analyst Decision
- JWN Hold
- KYMR Buy
- Analyst Count
- JWN 14
- KYMR 13
- Target Price
- JWN $20.15
- KYMR $51.15
- AVG Volume (30 Days)
- JWN 1.7M
- KYMR 415.6K
- Earning Date
- JWN 11-26-2024
- KYMR 10-31-2024
- Dividend Yield
- JWN 3.32%
- KYMR N/A
- EPS Growth
- JWN 804.21
- KYMR N/A
- EPS
- JWN 1.70
- KYMR N/A
- Revenue
- JWN $14,969,000,000.00
- KYMR $87,563,000.00
- Revenue This Year
- JWN $1.59
- KYMR N/A
- Revenue Next Year
- JWN $2.09
- KYMR $21.47
- P/E Ratio
- JWN $13.41
- KYMR N/A
- Revenue Growth
- JWN 1.02
- KYMR 86.92
- 52 Week Low
- JWN $13.68
- KYMR $17.89
- 52 Week High
- JWN $24.93
- KYMR $53.27
- Technical
- Relative Strength Index (RSI)
- JWN 49.75
- KYMR 34.56
- Support Level
- JWN $22.77
- KYMR $45.16
- Resistance Level
- JWN $23.60
- KYMR $53.23
- Average True Range (ATR)
- JWN 0.66
- KYMR 2.58
- MACD
- JWN -0.02
- KYMR -0.54
- Stochastic Oscillator
- JWN 35.58
- KYMR 1.66
About JWN Nordstrom Inc.
Nordstrom is a fashion retailer that operates about 93 department stores and approximately 260 off-price Nordstrom Rack stores. The company also operates both full- and off-price e-commerce sites, two clearance stores, and seven Local locations. Nordstrom's largest merchandise categories are women's apparel (27% of 2023 sales), shoes (26% of 2023 sales), men's apparel (15% of 2023 sales), and beauty (13% of 2023 sales). Nordstrom, which traces its history to a shoe store opened in Seattle in 1901, continues to be partially owned and managed by members of the eponymous family.
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a biotechnology company pioneering a transformative new approach to treating previously untreatable diseases. The company is advancing the field of targeted protein degradation, accessing the body's innate protein recycling machinery to degrade dysregulated, disease-causing proteins. Kymera's Pegasus targeted protein degradation platform harnesses the body's natural protein recycling machinery to degrade disease-causing proteins, with a focus on un-drugged nodes in validated pathways currently inaccessible with conventional therapeutics. It is accelerating drug discovery with an unmatched ability to target and degrade intractable proteins and advance new treatment options for patients.